Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Connect Twitter with Market Wire News

GBT News and Press Global Blood Therapeutics Inc.


home / stock / gbt / gbt news

RSS
GBT GBT Quote GBT Short GBT News GBT Articles GBT Message Board

News | Global Blood Therapeutics Inc. (NASDAQ:GBT)

  • GBT - Guerbet to Spotlight the Novel New Drug Elucirem(TM) (gadopiclenol) injection at the 2022 Radiological Society of North America Scientific Assembly and Annual Meeting

    Guerbet to Spotlight the Novel New Drug Elucirem™ (gadopiclenol) injection at the 2022 Radiological Society of North America Scientific Assembly and Annual Meeting PR Newswire Join us at Booth #1711 Opportunity to learn about the recently US FDA-approved nov...

    • November 22, 2022 07:21:00 pm
    • |
    • PR Newswire
    • |
      • GBT Stock
      • GBT Quote
      • GBT Short
      • GBT News
      • GBT Articles
      • GBT Message Board
  • GBT - Best Stocks To Buy For October 2022? 2 Healthcare Stocks In Focus

    The healthcare industry is growing at an unprecedented rate, and healthcare stocks are poised to benefit from this growth. This is large because healthcare companies are developing innovative new treatments and technologies that are transforming the way we care for our health. As a resu...

    • October 06, 2022 10:02:04 am
    • |
    • StockMarket.com
    • |
      • GBT Stock
      • GBT Quote
      • GBT Short
      • GBT News
      • GBT Articles
      • GBT Message Board
  • GBT - Global Blood Therapeutics expects to complete Pfizer deal in early October

    Global Blood Therapeutics ( NASDAQ: GBT ) expects to consummate its $5.4B deal with Pfizer ( NYSE: PFE ) on Oct. 5, the sickle cell disease drugmaker said in a regulatory filing on Friday. Pfizer ( PFE ) in early Aug. said it had agreed to buy GBT, with an ...

    • September 30, 2022 04:34:59 pm
    • |
    • SeekingAlpha
    • |
      • GBT Stock
      • GBT Quote
      • GBT Short
      • GBT News
      • GBT Articles
      • GBT Message Board
  • GBT - Tracking Baker Brothers Portfolio - Q2 2022 Update

    Summary Baker Brothers’ 13F portfolio value increased from $17.40B to $17.63B this quarter. Global Blood Therapeutics, Horizon Therapeutics, and Kymera Therapeutics were increased during the quarter. The top three positions are Seagen, Incyte Corporation, and BeiGene, a...

    • September 28, 2022 08:51:16 pm
    • |
    • SeekingAlpha
    • |
      • GBT Stock
      • GBT Quote
      • GBT Short
      • GBT News
      • GBT Articles
      • GBT Message Board
  • GBT - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EVOP, RFP, GBT, SBTX

    NEW YORK, NY / ACCESSWIRE / September 22, 2022 / New York, New York-Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: EVO Payments...

    • September 22, 2022 06:20:00 pm
    • |
    • ACCESSWIRE IA
    • |
      • GBT Stock
      • GBT Quote
      • GBT Short
      • GBT News
      • GBT Articles
      • GBT Message Board
  • GBT - Crispr: Elucidating And Forecasting Key Developments

    Summary In collaboration with stellar partners like Vertex, Crispr is aggressively expanding its robust pipeline of gene-edited medicine for various disorders. By year end, Crispr is poised to file a marketing application in Europe for exa-cel, a drug designed to treat blood disor...

    • September 21, 2022 04:54:14 am
    • |
    • SeekingAlpha
    • |
      • GBT Stock
      • GBT Quote
      • GBT Short
      • GBT News
      • GBT Articles
      • GBT Message Board
  • GBT - Global Blood Therapeutics: Pfizer Acquisition Signals Increasing M/A Deals

    Summary After a slow first half, merger and acquisition deals are heating up for the remainder of 2022. In the efforts to boost its presence in rare hematology, Pfizer recently announced it is acquiring Global Blood Therapeutics for $5.4B. Global Blood Therapeutics has several...

    • September 16, 2022 12:41:57 pm
    • |
    • SeekingAlpha
    • |
      • GBT Stock
      • GBT Quote
      • GBT Short
      • GBT News
      • GBT Articles
      • GBT Message Board
  • GBT - Regenxbio: A Transformative Year

    Summary Due to its tremendous pressure, the 2021/2022 Biotech Bear market knocked out nearly all biotech innovators. Nevertheless, certain rare companies like Regenxbio are defying bear market expectations. Asides from the recent AbbVie mega partnership, Regenxbio's RGX314 is ...

    • September 15, 2022 07:08:54 pm
    • |
    • SeekingAlpha
    • |
      • GBT Stock
      • GBT Quote
      • GBT Short
      • GBT News
      • GBT Articles
      • GBT Message Board
  • GBT - GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022

    SOUTH SAN FRANCISCO, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) announced its support for the Sickle Cell Disease Treatment Centers Act of 2022, which was introduced today and, if passed in its current form, would authorize f...

    • September 15, 2022 06:00:00 pm
    • |
    • GlobeNewswire
    • |
      • GBT Stock
      • GBT Quote
      • GBT Short
      • GBT News
      • GBT Articles
      • GBT Message Board
  • GBT - GBT and Sickle Cell Disease Association of America to Host 11th Annual Sickle Cell Disease Therapeutics Conference

    SOUTH SAN FRANCISCO, Calif. and BALTIMORE, Sept. 08, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) and the Sickle Cell Disease Association of America, Inc. (SCDAA) will host the 11 th Annual Sickle Cell Disease (SCD) Therapeutics Co...

    • September 08, 2022 08:00:00 am
    • |
    • GlobeNewswire
    • |
      • GBT Stock
      • GBT Quote
      • GBT Short
      • GBT News
      • GBT Articles
      • GBT Message Board
Next 10
Stock Information

Global Blood Therapeutics Inc. Company Name:

GBT Stock Symbol:

NASDAQ Market:

Get GBT Alerts

News, Short Squeeze, Breakout and More Instantly...

Ad

Connect Twitter with Market Wire News
RECENT GBT NEWS
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Join us on Telegram

Join us on Telegram

Join the Trending Stocks News on Telegram to get immediate news notifications!

Telegram


Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

Follow @marketwirenews

| Facebook

| Telegram

| LinkedIn

| Reddit

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2023 Market Wire News